3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
22
Leukemia, Myeloid, Acute
20
Breast Neoplasms
19
Neoplasm Metastasis
16
Pancreatic Neoplasms
15
Multiple Myeloma
13
Melanoma
12
Prostatic Neoplasms
11
Carcinoma, Non-Small-Cell Lung
11
Lymphoma
10
Colorectal Neoplasms
10
Carcinoma, Renal Cell
10
Burkitt Lymphoma
10
Triple Negative Breast Neoplasms
9
Urinary Bladder Neoplasms
8
Squamous Cell Carcinoma of Head and Neck
8
Ovarian Neoplasms
8
Mouth Neoplasms
8
Glioma
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Oropharyngeal Neoplasms
7
Myelodysplastic Syndromes
7
Leukemia, Lymphocytic, Chronic, B-Cell
7
Laryngeal Neoplasms
7
Fallopian Tube Neoplasms
7
Carcinoma, Hepatocellular
7
Carcinoma
7
Nasopharyngeal Carcinoma
6
Endometrial Neoplasms
6
Wilms Tumor
5
Interventions
Vincristine
2
Rituximab
2
Prednisone
2
Etoposide
2
Doxorubicin
2
Cyclophosphamide
2
liposomal doxorubicin
1
etoposide phosphate
1
Zidovudine
1
Valganciclovir
1
Sirolimus
1
Nivolumab
1
Interferon-alpha
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Bortezomib
1
Biological Assay
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoproliferative Disorders
×
Specimen Handling
×
30 days
×
Clear all
No trials found.